Published in Hepatitis Weekly, September 22nd, 1997
HCV is the predominate cause of hepatocellular carcinoma (HCC) in infected persons. Community-acquired HCV infection is common and causes significant morbidity and economic burden. The lack of efficient antiviral treatments for HCV emphasizes the importance of the search for an effective vaccine.
Isao Nakano and colleagues from the Institute Pasteur de Lille and INSERM in France, and INNOGENETICS in Belgium, collaborated to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.